CERo Therapeutics prices $5M public offering of shares and warrants at $1.96/unit

CERO THERAPEUTICS HOLDINGS, INC.

Offering of 2,551,020 shares and warrants at combined $1.96 price; gross proceeds ~$5M.
Warrants exercisable at $1.96 upon shareholder approval, expire 5 years from exercise date.
Closing expected February 7, 2025; net proceeds for clinical programs and working capital.
A.G.P./Alliance Global Partners as placement agent; board member and institutional investor participating.
90-day lock-up for officers/directors; company restricted from variable rate financings for 180 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.